Wednesday, February 24, 2021

Peru suspends clinical trials of Chinese Covid vaccine

60,000 across the globe have already taken the Sinopharm vaccine, including volunteers in Argentina, Russia and Saudi Arabia.

Other News

Global digital vaccination travel passport ready ‘within weeks’

As the pandemic continues, governments are preparing to only allow vaccinated tourists to enter their countries.

Guinea launches Ebola vaccination campaign

Guinea's health minister expects an end to the outbreak in about six weeks.

SolarWinds hack required massive, sophisticated effort, says Microsoft head

Microsoft, one of more than 100 companies attacked and 18,000 left vulnerable by the hack, has analysed the work it took to insert malware into widely used security software created by SolarWinds.

AstraZeneca EU supply chain shortfall continues in second quarter

The British-Swedish company had sparked fury among European leaders by announcing that it would miss its target of supplying the EU with 400 million doses, due to a shortfall at the firm's European plants.

Israel sends vaccine ‘gifts’ to friendly nations

But the right-wing premier, who describes Jerusalem as the Jewish state’s 'undivided capital', cheers nations that conduct diplomacy with Israel from the disputed city.

Peru has temporarily suspended clinical trials of a Covid-19 vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.

The National Institute of Health said Friday that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.

“Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.

Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.

In the 1970s a campaign to inoculate Americans against a supposedly devastating strain of swine flu ground to a halt after some 450 of those vaccinated developed the syndrome, which can also cause paralysis.

Peru’s clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.

If they are successful – which won’t be known until mid-2021 – the Peruvian government was expected to buy up to 20 million doses to inoculate two-thirds of its population.

60,000 across the globe have already taken the Sinopharm vaccine, including volunteers in Argentina, Russia and Saudi Arabia.

Peru has one of the world’s highest per capita death rate from the virus, which as of Friday had caused 36,499 deaths and 979,111 infections.

The pandemic has hit the South American country’s economy hard, with GDP plunging more than 30% in the second quarter.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Global digital vaccination travel passport ready ‘within weeks’

As the pandemic continues, governments are preparing to only allow vaccinated tourists to enter their countries.

AstraZeneca EU supply chain shortfall continues in second quarter

The British-Swedish company had sparked fury among European leaders by announcing that it would miss its target of supplying the EU with 400 million doses, due to a shortfall at the firm's European plants.

Israel sends vaccine ‘gifts’ to friendly nations

But the right-wing premier, who describes Jerusalem as the Jewish state’s 'undivided capital', cheers nations that conduct diplomacy with Israel from the disputed city.

Rising violence mars start of Afghanistan’s Covid-19 vaccination drive

Taliban insurgents fighting the government have announced their backing for the vaccination campaign.

Muhyiddin to receive first Pfizer jab today

Also scheduled to receive the vaccine today are health director-general Dr Noor Hisham Abdullah and four other staff from the health ministry.